Management of Postoperative Recurrence of Crohn's Disease
Authors:
- Geert R. D'HAensGDGeert R. D'HAens
- 1 September 2013
- journal article
- research article
- Published by S. Karger AG in Digestive Diseases
- Vol. 31 (2) , 222-228
Abstract
The course of Crohn's disease (CD) is unpredictable and potentially destructive. The percentage of patients requiring surgery at some stage in their disease accumulates to over 70%. After resection of the affected intestine, reappearance of CD occurs in the majority of patients. Prophylactic medical therapy to reduce the rate of postoperative recurrence has been proven to be effective, yet the incidence of recurrence remains high. Patient profiling (risk stratification) is important in this postoperative setting. High-risk patients (associated with e.g. smoking, the need of repetitive surgery and penetrating disease) require strong immunosuppressive treatment, which should be commenced immediately after surgery, when recurrent disease activity begins. Additionally, early screening endoscopy should be performed to monitor treatment effect. The efficacy of thiopurines is shown to be higher than mesalazine or imidazole antibiotics alone for preventing and ameliorating endoscopic recurrence of CD postoperatively; however, anti-tumor necrosis factors (anti-TNFs) are increasingly considered the most potent agents. In patients with a risk factor for early postoperative recurrence, the first line of treatment is 6-mercaptopurine, in combination with imidazole antibiotics if tolerated, followed by anti-TNFs. When lesions are found at colonoscopy, therapy should be upscaled. We propose a treatment algorithm to direct therapeutic management of CD postoperatively.Keywords
This publication has 28 references indexed in Scilit:
- Clinical factors predictive of Crohn’s disease complications and surgeryEuropean Journal of Gastroenterology & Hepatology, 2013
- Diagnosis, prevention and treatment of postoperative Crohn's disease recurrenceDigestive and Liver Disease, 2012
- Impact of environmental and dietary factors on the course of inflammatory bowel diseaseWorld Journal of Gastroenterology, 2012
- Pathogenesis of postoperative recurrence in Crohn's diseaseGut, 2010
- Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trialGut, 2010
- Interventions for prevention of post-operative recurrence of Crohn's diseaseCochrane Database of Systematic Reviews, 2009
- Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized TrialGastroenterology, 2008
- Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's diseaseBritish Journal of Surgery, 2000
- Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.Gut, 1992
- Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.Gut, 1984